Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 119.42B | 120.64B | 117.90B | 98.17B | 84.50B | 80.23B |
Gross Profit | 20.90B | 21.43B | 18.70B | 11.21B | 12.98B | 15.47B |
EBITDA | 14.32B | 14.28B | 14.80B | 7.88B | 9.42B | 10.62B |
Net Income | 3.58B | 3.96B | 5.04B | 1.17B | 2.10B | 2.70B |
Balance Sheet | ||||||
Total Assets | 137.58B | 138.40B | 137.73B | 126.13B | 115.63B | 115.62B |
Cash, Cash Equivalents and Short-Term Investments | 49.65B | 49.92B | 45.36B | 42.70B | 38.98B | 38.42B |
Total Debt | 19.58B | 18.43B | 18.61B | 25.79B | 21.10B | 20.04B |
Total Liabilities | 49.20B | 46.67B | 50.22B | 50.60B | 43.17B | 44.41B |
Stockholders Equity | 84.84B | 87.94B | 84.54B | 71.94B | 68.63B | 67.03B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.61B | 10.33B | 30.00M | 171.00M | 1.64B |
Operating Cash Flow | 0.00 | 9.24B | 14.88B | 5.24B | 4.16B | 6.38B |
Investing Cash Flow | 0.00 | -4.34B | -5.16B | -4.68B | -4.97B | -3.06B |
Financing Cash Flow | 0.00 | -2.88B | -9.40B | 1.48B | -897.00M | 6.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥128.34B | 10.85 | ― | 3.65% | 1.71% | -11.98% | |
78 Outperform | ¥115.92B | 31.61 | ― | 6.19% | -1.11% | -33.77% | |
74 Outperform | ¥30.05B | 10.87 | ― | 4.42% | 0.65% | -21.13% | |
72 Outperform | ¥4.32B | 9.30 | ― | 2.70% | -2.63% | -27.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥80.74B | 54.22 | ― | 1.75% | 8.25% | -31.16% | |
53 Neutral | ¥2.83B | ― | ― | 3.21% | 5.04% | -258.52% |